Got Ideas For Reducing Industry's Regulatory Burden? FDA Wants To Know
This article was originally published in The Rose Sheet
CFSAN and other FDA centers ask for "broad public comment" the agency will use "to guide our initial review of our regulations" required in President Trump's January executive order for federal agencies to "evaluate existing regulations and identify those that may merit repeal, replacement, or modification."
You may also be interested in...
Expiration dates in HHS’ final SUNSET rule exclude OTC drugs after CCHPA and other groups argue the rule would create more problems than it would solve. But dietary supplement regulations are subject to the rule.
Any movement to advance proposed cosmetics reform legislation could be seen as running counter to President Trump's executive orders earlier this year, which now have FDA centers seeking "broad public comment" on how to achieve "meaningful burden reduction."
Woodward keynotes CRN's Conference; GMPs on AHPA's reg comment radar; Unilever acquires Pukka Herbs; CVS brand consumer health products in vending machines; and more news in brief.